Disclosures for "Adult-onset Biotinidase Deficiency with Partial Remission Misdiagnosed as NMO"
-
Ms. Fedorova has nothing to disclose.
-
Dr. Kacpura has nothing to disclose.
-
Dr. Babiuch has received personal compensation for serving as an employee of Genentech.
-
Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Kosmorsky has nothing to disclose.
-
Dr. Andrapalliyal has nothing to disclose.